Chandigarh
3 Day Global Medical Conference Begins In Chandigarh
IMTechCon 2017 Conference
Chandigarh: International Conference at CSIR-Institute of Microbial Technology
A three-day international conference, aimed at engaging industry and academic leaders to discuss current unmet medical needs, began at CSIR-Institute of Microbial Technology (IMTECH).
CSIR-IMTECH is a premier microbial institute under the aegis of the Union Ministry of Science and Technology.
The aim of the conference 'IMTechCon 2017' is to engage industry and academic leaders to discuss current unmet medical needs globally, IMTECH Director Anil Koul said.
The conference was presided over by Haryana Governor Kaptan Singh Solanki, who said that such close interactions will forge new R&D partnerships between industry and research institutions and lead to more product/technology development output.
"Partnerships between industry and academia have yielded great strides in research for IMTECH as has been witnessed by therapeutic use of clot buster Streptokinase for the public at large at affordable cost," the Governor added.
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
0 Comments
Post a comment
No comments yet. Be the first to comment!